Altimmune Inc
NASDAQ:ALT

Watchlist Manager

Altimmune Inc

NASDAQ:ALT

Watchlist

Dividends

Price: 7.71 USD 7.23% Market Closed

Market Cap: 593.7m USD

Have any thoughts about
Altimmune Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 7.71 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

ALT Alert

Altimmune Inc

7.71

+0.52 (+7.23%)

52 Week Range	3.67 9.85
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Altimmune Inc

What unique competitive advantages
does Altimmune Inc hold over its rivals?

What risks and challenges
does Altimmune Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Altimmune Inc.

What unique competitive advantages
does Altimmune Inc hold over its rivals?

What risks and challenges
does Altimmune Inc face in the near future?

Has there been any significant insider trading activity
in Altimmune Inc recently?

Summarize the latest earnings call
of Altimmune Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Altimmune Inc.

Provide P/S
for Altimmune Inc.

Provide P/E
for Altimmune Inc.

Provide P/OCF
for Altimmune Inc.

Provide P/FCFE
for Altimmune Inc.

Provide P/B
for Altimmune Inc.

Provide EV/S
for Altimmune Inc.

Provide EV/GP
for Altimmune Inc.

Provide EV/EBITDA
for Altimmune Inc.

Provide EV/EBIT
for Altimmune Inc.

Provide EV/OCF
for Altimmune Inc.

Provide EV/FCFF
for Altimmune Inc.

Provide EV/IC
for Altimmune Inc.

Show me price targets
for Altimmune Inc made by professional analysts.

What are the Revenue projections
for Altimmune Inc?

How accurate were the past Revenue estimates
for Altimmune Inc?

What are the Net Income projections
for Altimmune Inc?

How accurate were the past Net Income estimates
for Altimmune Inc?

What are the EPS projections
for Altimmune Inc?

How accurate were the past EPS estimates
for Altimmune Inc?

What are the EBIT projections
for Altimmune Inc?

How accurate were the past EBIT estimates
for Altimmune Inc?

Compare the revenue forecasts
for Altimmune Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Altimmune Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Altimmune Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Altimmune Inc compared to its peers.

Compare the P/E ratios
of Altimmune Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Altimmune Inc with its peers.

Analyze the financial leverage
of Altimmune Inc compared to its main competitors.

Show all profitability ratios
for Altimmune Inc.

Provide ROE
for Altimmune Inc.

Provide ROA
for Altimmune Inc.

Provide ROIC
for Altimmune Inc.

Provide ROCE
for Altimmune Inc.

Provide Gross Margin
for Altimmune Inc.

Provide Operating Margin
for Altimmune Inc.

Provide Net Margin
for Altimmune Inc.

Provide FCF Margin
for Altimmune Inc.

Show all solvency ratios
for Altimmune Inc.

Provide D/E Ratio
for Altimmune Inc.

Provide D/A Ratio
for Altimmune Inc.

Provide Interest Coverage Ratio
for Altimmune Inc.

Provide Altman Z-Score Ratio
for Altimmune Inc.

Provide Quick Ratio
for Altimmune Inc.

Provide Current Ratio
for Altimmune Inc.

Provide Cash Ratio
for Altimmune Inc.

What is the historical Revenue growth
over the last 5 years for Altimmune Inc?

What is the historical Net Income growth
over the last 5 years for Altimmune Inc?

What is the current Free Cash Flow
of Altimmune Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Altimmune Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

ALT Price Targets Summary
Altimmune Inc

Wall Street analysts forecast ALT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALT is 22.29 USD with a low forecast of 12.12 USD and a high forecast of 29.4 USD.

Lowest

Price Target

12.12 USD

57% Upside

Average

Price Target

22.29 USD

189% Upside

Highest

Price Target

29.4 USD

281% Upside

Altimmune Inc Competitors:
Price Targets

2487

Cutia Therapeutics

25% Upside

BIOCON

Biocon Ltd

11% Upside

GILD

Gilead Sciences Inc

11% Upside

BCRX

BioCryst Pharmaceuticals Inc

82% Upside

2487

Cutia Therapeutics

25% Upside

BIOCON

Biocon Ltd

11% Upside

GILD

Gilead Sciences Inc

11% Upside

BCRX

BioCryst Pharmaceuticals Inc

82% Upside

4974

Takara Bio Inc

61% Upside

002675

Yantai Dongcheng Biochemicals Co Ltd

9% Upside

086900

Medy Tox Inc

29% Upside

OCX

OncoCyte Corp

75% Upside

Revenue
Forecast

Revenue Estimate
Altimmune Inc

For the last 8 years the compound annual growth rate for Altimmune Inc's revenue is -47%. The projected CAGR for the next 3 years is 1 087%.

-47%

Past Growth

1 087%

Estimated Growth

Estimates Accuracy

11%

Average Beat

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Altimmune Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-8%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Altimmune Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-62%

Average Miss

What are analyst estimates?

What is ALT's stock price target?

Price Target
22.29 USD

According to Wall Street analysts, the average 1-year price target for ALT is 22.29 USD with a low forecast of 12.12 USD and a high forecast of 29.4 USD.

What is Altimmune Inc's Revenue forecast?

Projected CAGR
1 087%

For the last 8 years the compound annual growth rate for Altimmune Inc's revenue is -47%. The projected CAGR for the next 3 years is 1 087%.

	Franklin Covey Co NYSE:FC	22.59 USD -1.7%
	Mohawk Industries Inc NYSE:MHK	103.28 USD 0.65%
	Ardmore Shipping Corp NYSE:ASC	9.87 USD -2.08%
	ASGN Inc NYSE:ASGN	50.01 USD 0.24%
	Skyworks Solutions Inc NASDAQ:SWKS	74.48 USD 0.28%
	Weatherford International PLC NASDAQ:WFRD	49.82 USD 4.29%

	Johnson & Johnson NYSE:JNJ	152.01 USD -0.18%
	Bank of America Corp NYSE:BAC	47.46 USD 1.3%
	Mastercard Inc NYSE:MA	545.81 USD -0.71%
	Salesforce Inc NYSE:CRM	270.74 USD 1.11%
	Abbvie Inc NYSE:ABBV	186.79 USD 0.76%
	Home Depot Inc NYSE:HD	363.5 USD 0.45%

	Arista Networks Inc NYSE:ANET	101.59 USD 5.48%
	Deckers Outdoor Corp NYSE:DECK	101.93 USD 0.88%
	Visa Inc NYSE:V	346.03 USD 0.22%
	Texas Pacific Land Corp NYSE:TPL	1 066.78 USD 2.94%
	KLA Corp NASDAQ:KLAC	902.94 USD 1.06%
	Manhattan Associates Inc NASDAQ:MANH	193.84 USD 1.23%

	Salesforce Inc NYSE:CRM	270.74 USD 1.11%
	Accenture PLC NYSE:ACN	296.08 USD 0.5%
	ServiceNow Inc NYSE:NOW	1 011.44 USD 0.62%
	Spotify Technology SA NYSE:SPOT	775.9 USD 5.38%
	EOG Resources Inc NYSE:EOG	121.13 USD 1.09%
	Monster Beverage Corp NASDAQ:MNST	62.19 USD -0.02%

Altimmune Inc
NASDAQ:ALT